Fabio
93 lines
7.0 KiB
Markdown
93 lines
7.0 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Public health: omnibus bill."
|
||
description: "(1) Under existing law, a licensed health care provider who is authorized by law to prescribe an opioid antagonist may, if acting with reasonable care, prescribe and subsequently dispense or distribute an opioid antagonist to a person at risk of an opioid-related overdose or to a family member, friend, or other person in a position to assist a person at risk of an opioid-related overdose. Existing law defines \"opioid antagonist\" for this purpose to mean naloxone hydrochloride that is approved by the United States Food and Drug Administration for the treatment of an opioid overdose."
|
||
jurisdiction: "us/states/ca"
|
||
legislature: "California Legislature"
|
||
session: "20212022"
|
||
identifier: "SB 823"
|
||
citation: "California SB 823 (20212022)"
|
||
classification: ["bill"]
|
||
subjects: ["Public health: omnibus bill."]
|
||
status: "enacted"
|
||
primary_sponsors: ["Committee on Health"]
|
||
version_count: 7
|
||
action_count: 25
|
||
vote_count: 6
|
||
first_action: "2021-03-10"
|
||
last_action: "2021-10-05"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/47b86356-6da6-4757-b421-c5255938f11e"
|
||
source_url: "http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202120220SB823"
|
||
source_hash: "74ae426b6a2cb0204bf26c5c0b7857e778fe90f407f2bcce241b029c45d45d47"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-ca"]
|
||
---
|
||
|
||
# California SB 823 (20212022) — Public health: omnibus bill.
|
||
|
||
(1) Under existing law, a licensed health care provider who is authorized by law to prescribe an opioid antagonist may, if acting with reasonable care, prescribe and subsequently dispense or distribute an opioid antagonist to a person at risk of an opioid-related overdose or to a family member, friend, or other person in a position to assist a person at risk of an opioid-related overdose. Existing law defines "opioid antagonist" for this purpose to mean naloxone hydrochloride that is approved by the United States Food and Drug Administration for the treatment of an opioid overdose.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **03/10/21 - Introduced** (filed) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=202120220SB823&version=20210SB82399INT)
|
||
2. **04/05/21 - Amended Senate** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=202120220SB823&version=20210SB82398AMD)
|
||
3. **06/10/21 - Amended Assembly** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=202120220SB823&version=20210SB82397AMD)
|
||
4. **09/01/21 - Amended Assembly** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=202120220SB823&version=20210SB82396AMD)
|
||
5. **10/05/21 - Chaptered** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=202120220SB823&version=20210SB82394CHP)
|
||
6. **SB823** (committee substitute) — [source](http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202120220SB823)
|
||
7. **09/10/21 - Enrolled** (enrolled) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=202120220SB823&version=20210SB82395ENR)
|
||
|
||
## Votes
|
||
|
||
- Do pass. — **16–0** (pass) · lower
|
||
- Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar — **15–0** (pass) · lower
|
||
- Do pass, but first be re-referred to the Committee on [Appropriations] with the recommendation: To Consent Calendar — **11–0** (pass) · upper
|
||
- SB 823 HEALTH Senate Third Reading By WOOD — **71–0** (pass) · lower
|
||
- Consent Calendar SB823 HEALTH — **37–0** (pass) · upper
|
||
- Unfinished Business SB823 HEALTH (Pan) Concurrence — **38–0** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Committee on Health — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2021-03-10** Introduced. Read first time. To Com. on RLS. for assignment. To print. `introduction, reading-1`
|
||
- **2021-03-10** Article IV Section 8(a) of the Constitution and Joint Rule 55 dispensed with February 22, 2021, suspending the 30 calendar day requirement.
|
||
- **2021-03-11** From printer.
|
||
- **2021-03-18** Referred to Com. on HEALTH. `referral-committee`
|
||
- **2021-03-26** Set for hearing April 14.
|
||
- **2021-04-05** From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH. `amendment-passage, committee-passage, reading-1, reading-2, referral-committee`
|
||
- **2021-04-14** From committee: Do pass and re-refer to Com. on APPR with recommendation: To consent calendar. (Ayes 11. Noes 0. Page 795.) (April 14). Re-referred to Com. on APPR. `committee-passage, committee-passage-favorable, referral-committee`
|
||
- **2021-04-21** Set for hearing May 3.
|
||
- **2021-05-04** From committee: Be ordered to second reading pursuant to Senate Rule 28.8 and ordered to consent calendar. `committee-passage, reading-2`
|
||
- **2021-05-05** Read second time. Ordered to consent calendar. `reading-1, reading-2`
|
||
- **2021-05-10** Read third time. Passed. (Ayes 37. Noes 0. Page 1062.) Ordered to the Assembly. `passage, reading-1, reading-3`
|
||
- **2021-05-10** In Assembly. Read first time. Held at Desk. `reading-1`
|
||
- **2021-05-20** Referred to Com. on HEALTH. `referral-committee`
|
||
- **2021-06-10** From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH. `amendment-passage, committee-passage, reading-1, reading-2, referral-committee`
|
||
- **2021-07-07** From committee: Do pass and re-refer to Com. on APPR. with recommendation: To consent calendar. (Ayes 15. Noes 0.) (July 6). Re-referred to Com. on APPR. `committee-passage, committee-passage-favorable, referral-committee`
|
||
- **2021-08-19** From committee: Do pass. (Ayes 16. Noes 0.) (August 19). `committee-passage, committee-passage-favorable`
|
||
- **2021-08-23** Read second time. Ordered to third reading. `reading-1, reading-2`
|
||
- **2021-09-01** Read third time and amended. `amendment-passage, reading-1, reading-3`
|
||
- **2021-09-01** Ordered to third reading.
|
||
- **2021-09-07** Read third time. Passed. (Ayes 71. Noes 0. Page 2816.) Ordered to the Senate. `passage, reading-1, reading-3`
|
||
- **2021-09-07** In Senate. Concurrence in Assembly amendments pending.
|
||
- **2021-09-08** Assembly amendments concurred in. (Ayes 38. Noes 0. Page 2525.) Ordered to engrossing and enrolling. `amendment-passage, committee-passage-favorable`
|
||
- **2021-09-13** Enrolled and presented to the Governor at 3:30 p.m.
|
||
- **2021-10-05** Approved by the Governor. `executive-signature`
|
||
- **2021-10-05** Chaptered by Secretary of State. Chapter 554, Statutes of 2021. `became-law`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/47b86356-6da6-4757-b421-c5255938f11e`. Confidence: reported (aggregated from official California legislature records).
|
||
|